Role of Dobutamine Stress Echocardiography in
Prediction Of Clinical and Functional Improvement after
Coronary Artery Bypass Grafting in Patients with Low Ejection Fraction
Ismail Nasr
El-Sokkary1[*]
MD, Esam Ahmed Khalil2 MD, Mohamed Hossiny Mahmoud1 MD, Bahaa Abd-elgawad
Elkhonezy1 MD, Hatem
Aboalazayem1 MD, M.Sh Elfeky1 MD,
Mahmoud Ibrahim Elshamy3 MD, Arafa G.
Ibrahim4 MD, Mahmoud F. Elshahat4 MD, Mohamed Kamal Rehan5 MD.
(1)
Department of Cardiovascular & Thoracic Surgery,
Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
(2)
Department of Cardiology, Al-Azhar
University, Faculty of Medicine, Cairo, Egypt.
(3) Department
of Radio diagnosis, Faculty of Medicine, Al-Azhar University,
Cairo, Egypt.
(4) Department
of Cardiology, Faculty of Medicine, Helwan University,
Cairo, Egypt.
(5) Department
of Internal Medicine, Faculty of Medicine, Beni Suef University, Cairo, Egypt.
ARTICLE DETAILS ABSTRACT
In patients with ischemic heart disease, surgical coronary artery
revascularization has considerably increased survival by lowering mortality rate
and the occurrence of sudden cardiac death by of 25% and 50%respectively (1).
The advantages of having viable myocardium in the area undergoing
revascularization outweigh the higher operational risk in patients with poor
ejection fraction (EF). Additionally, it has been proven that coronary artery
bypass graft (CABG) is more beneficial than conservative treatment in patients
with low EF but viable myocardium (2).
With adrenergic stimulation provided by dopamine, isoproterenol, and dobutamine, impaired regional function brought on by
myocardial stunning or a hibernating myocardium can be reversed. If
contractility was improved in at least four parts, the test was deemed
successful. likelihood of improved regional wall motion and LV function,
improved New York Heart Association (NYHA) class, and increased mortality
following successful surgical coronary revascularization increases with the
degree and extent of viable myocardial segments present prior to surgery (3).
This study conducted on patients with multi-vessels disease with low EF undergo Coronary
artery bypass graft (CABG) to predict surgical outcome and shows significant
improvement of cardiac function after cardiac surgery based on the results of dobutamine-stress echocardiography (DSE) and follow up
after six months.
2.1 Study design.
This study was a descriptive cohort study which was conducted at the Al-Azhar University hospitals in Cairo, Egypt.
This
study aimed to evaluate the outcomes following coronary
artery bypass graft (CABG) in 100 patients with low ejection fraction and to
identify potential associated factors of postoperative outcome based on the
results of dobutamine-stress echocardiography (DSE).
2.2 Inclusion and exclusion criteria
100 Patients were recruited from Cardiothoracic Surgery and Cardiology
Departments at Al-Azhar University during the
study period of a year with a 6-month follow-up were included in the current
study according to the following.
Inclusion criteria: patients with chronic stable coronary artery
disease (CAD) undergoing isolated, elective, on-pump CABG with low ejection
fraction (EF≤40%) on trans-thoracic echocardiography (TTE)
The exclusion criteria including Patients
with concomitant valve replacement, previous cardiac surgery, Redo-CABG,
emergency CABG, hepatic or renal failure, ventricular or aortic aneurysmal
repair, overt peripheral vascular disease, surgery for arrhythmia, repair of
ventricular septal perforation, concomitant carotid
artery surgery, recent myocardial infarction, or acute coronary artery syndrome.
2.3 Sampling technique
A consecutive sample of all patients admitted to Cardiothoracic Surgery
and Cardiology Departments at Al-Azhar University
during the study period 2 years from September 2021 to august
2023 and meeting the inclusion criteria were selected to be participants in the
current study.
2.4 Data collection
All the study participants were subjected to the following:
Routine preoperative laboratory and radiological
investigations for cardiac surgery including angiographic and echocardiographic
studies. Dobutamine Stress Echocardiography (DSE) was
performed using a 16-segment model analysis in in which intravenous
administration of Dobutamine was started at a dose of 5.0 μg/kg/min and
increased by 5–10 μg/kg/min every 3 minutes up
to a maximum of 40 μg/kg/min, or until a study
endpoint was achieved. Study participants were instructed to avoid taking drugs
with a positive inotropic action 3 days prior to the test. Conventional on-pump
CABG through median sternotomy with standardized
anesthetic and surgical techniques. After surgery, patients were managed at
Cardiothoracic Surgery ICU. Echocardiography was performed within one week
after CABG and at the end of 6 months after surgery during the follow-up.
2.5
Ethical considerations
A
written informed consent was obtained from all participants. Confidentiality of
data was assured, and data collection forms were anonymous. The study protocol
was approved by the Scientific Research Ethical Committee of Faculty of
Medicine, Al-Azhar University under IRB Registration number.
2.6
Statistical analysis
Data were analyzed using IBM Statistical
Package for Social Science (SPSS) Statistics for Windows version 20.0 and MedCalc software version 15.8.0. Quantitative data were
expressed as median and inter quartile range. Qualitative data were expressed
as number and percentage. Data were tested for normality using the Shapiro-Wilk test. Independent samples t
test was applied for normally distributed data. The nonparametric Mann–Whitney
test was used for data which were not normally distributed. Chi-square
(χ2) test and Fisher's Exact Test were used for comparison of qualitative
variables as appropriate. The confidence interval was set to 95% and the
margin of error accepted was set to 5%.
In relation to the sociodemographic data of the studied patients, the
current study estimates that mean age of study participants was 50.32 ± 6.32
years, 35.0% were male while 65.0% were female, 62.0% and 58.0% had D.M and HTN
with mean Euro score II of 1.45 ± 0.11. respectively.
47.0% of the studied patients were ex-smokers and 24.0% still smokers. there was a relative increase in the frequency of obese
patients with body mass index (BMI) > 30 kg/m2 (58.0%). Most of the patients
were smokers (47.0% ex-smokers and 24.0% still smokers), In relation to the
medical health history of the studied patients, the current study mentions that
(70% and 72.0%,61% and 14%) of the studied patients had NYHA functional class
III respectively .and CCS angina grade III, 3-vessels disease and left main
stem disease. Also, the studied patients were receiving Beta-blockers and statins by (64% and 39%)
respectively. Concerning the Changes in the findings of
trans-thoracic echocardiography pre & postoperatively and at the end of
follow-up period in survivors. The current study shows that the
studied patients had preoperative left ventricular
end-diastolic diameter (LVEDD), left ventricular end-systolic diameter (LVESD)
and left ventricular ejection fraction (LVEF) of 5.12 ± 0.45 cm of 4.25 ± 0.21 cm and 40.32
± 1.36. respectively. while
the same parameters were 4.97 ± 0.37,3.96 ± 0.21 and 56.21 ± 3.21 postoperatively. Also, the studied patients had left ventricular end-diastolic diameter (LVEDD), left
ventricular end-systolic diameter (LVESD) and left ventricular ejection
fraction (LVEF) of 4.95 ± 0.42,3.46 ±
0.31 and 59.7 ± 4.25 respectively in the follow up period. Regarding SWAM, the apical contraction on TTE was
presented as hypokinesia, akinesia and dyskinesia by (28.0%, 47.0% and 25.0%)
respectively, while the same parameters were 48 %, 5% and 0%) postoperatively
while the apical contraction on TTE was presented as hypokinesia,
akinesia and dyskinesia by (43% ,4% and 0%) respectively
in the follow up period. There was highly statistical significance between the
findings of trans-thoracic echocardiography pre & postoperatively and at
the end of follow-up period
in which p<0.001, All these results showed in
Table (1).
Table 1: Changes in the findings of trans-thoracic
echocardiography postoperatively and at the end of follow-up period in
survivors
|
Preoperative |
Postoperative |
Follow-up |
Test Value |
P-value |
Sig. |
|
LVEDD (cm) |
5.12 ± 0.45 |
4.97 ± 0.37 |
4.95 ± 0.42 |
5.021 |
0.007 |
HS |
|
LVESD (cm) |
4.25 ± 0.21 |
3.96 ± 0.21 |
3.46 ± 0.31 |
259.957 |
0.000 |
HS |
|
LVEF (%) |
40.32 ± 1.36 |
56.21 ± 3.21 |
59.7 ± 4.25 |
1059.459 |
0.000 |
HS |
|
SWMA |
– |
– |
– |
||||
- Normal |
0 (0%) |
47 (47%) |
53 (53%) |
170.538 |
0.000 |
HS |
|
- Hypokinesia |
28 (28.0%) |
48 (48 %) |
43 (43%) |
||||
- Akinesia |
47 (47.0%) |
5 (5%) |
4 (4%) |
||||
- Dyskinesia |
25 (25.0%) |
0 (0%) |
0 (0%) |
In relation to
Multivariable analysis of the associated factors of in-hospital mortality after
CABG in patients with low LVEF (Cox Proportional Hazards Regression Analysis,
the current study shows that Insertion of IABP is highly significant associated
factor within hospital mortality p<0.001), On
multivariable analysis of the predictors of in-hospital mortality (Table 2),
the insertion of IABP was the only significant predictor of mortality.
Table 2: Multivariable analysis of the predictors of
in-hospital mortality after CABG in patients with low LVEF (Cox Proportional
Hazards Regression Analysis)
|
OR |
95% CI |
P-value |
Age > 60 years |
4.12 |
0.79-12.9 |
0.121 |
Peak WMSI on DSE >1.5 |
3.90 |
0.85-17.52 |
0.089 |
Improvement of LVEF on DSE <10% |
2.31 |
0.35-14.67 |
0.420 |
Insertion of IABP |
6.18 |
1.45-26.90 |
0.001* |
Incomplete revascularization |
5.66 |
0.47-72.99 |
0.190 |
About Multivariable
analysis of the predictors of functional non-recovery after CABG in patients
with low LVEF (Binary Logistic Regression Analysis) the current study mentions
that Peak WMSI on DSE >1.5, Improvement of
LVEF on DSE <10% and Incomplete revascularization were at odd ratio
and 95% IC of (4.72, 9.45 and 29.89)
respectively. The improvement of LVEF on DSE <10% and incomplete
revascularization were significant associated factors of functional
non-recovery. All these results are shown in Table (3). Regarding
preoperative extent of coronary artery disease, the current study shows that
coronary revascularization was complete in 74.0% and incomplete in 26.0%.
Coming off bypass required inotropes in 49.0% and IABP in 10.0%.
Table 3: Multivariable analysis of the predictors of functional non-recovery
after CABG in patients with low LVEF (Binary Logistic Regression Analysis)
|
OR |
95% CI |
P-value |
Peak WMSI on DSE >1.5 |
4.72 |
0.59-41.43 |
0.162 |
Improvement of LVEF on DSE <10% |
9.45 |
1.39-62.58 |
0.002* |
Incomplete revascularization |
29.89 |
5.59-196 |
<0.001* |
In relation to the Postoperative complications,
the current study showed that low cardiac output arrhythmia reopening for
bleeding (Sternal wound infection, pulmonary complications (and renal
complications were presented in (57.0%,15.0%,5.0%,3.0%,7.0% and 2.0%) of the
studied patients respectively. The mean duration of mechanical ventilation and
hospital stay was 25.32 ± 11.01 hours
and 10.36 ± 2.36 days respectively. While
the incidence of 30-day (in-hospital) mortality was 9.0%. Regarding the NYHA Functional class and CCS angina, there were highly
statistically significant differences when comparing pre-operative and follow
up after surgery p<0.001.
Discussion
Coronary artery disease (CAD) is one
manifestation of ischemic heart disease, which is the leading cause of
mortality in the world. In addition to preventive medical therapy and lifestyle
changes, consideration of revascularization of obstructed arteries to reduce
ischemia, alleviate angina, and improve quality of life is a mainstay of
current practice (4).
Coronary artery revascularization can be
performed surgically or percutaneously. Surgery is
associated with higher procedural risk and longer recovery than percutaneous
interventions, but with long-term reduction of recurrent cardiac events. For
many patients with obstructive coronary artery disease in need of revascularization,
surgical or percutaneous intervention is indicated based on clinical and
anatomical reasons or personal preferences. Medical therapy is a crucial
accompaniment to coronary revascularization, and data suggest that, in some
subsets of patients, medical therapy alone might achieve similar results to
coronary revascularization (5)
CABG for dysfunction but viable myocardium
enhances LV recovery of function and ensures acceptable survival. The results
of DSE in patients with low LVEF are predictive for clinical improvement.
Therefore, assessment of wall motion score index and LVEF with dobutamine echocardiography may be the optimal means of
evaluating the impact of viability on prognosis (6)
The aim of this study was to evaluate the
outcomes following coronary artery bypass graft (CABG) in 100 patients with low
ejection fraction and to identify potential associated factors of postoperative
outcome based on the results of dobutamine-stress
echocardiography (DSE).
In relation to the sociodemographic data of the studied patients, the
current study estimates that mean age of study participants was 50.32 ± 6.32
years, 35.0% were male while 65.0% were female, 62.0% and 58.0% had D.M and HTN
with mean Euro score II of 1.45 ± 0.11. respectively.
47.0% of the studied patients were ex-smokers and 24.0% still smokers. there was a relative increase in the frequency of obese
patients with body mass index (BMI) > 30 kg/m2 (58.0%). Most of the patients
were smokers (47.0% ex-smokers and 24.0% still smokers) in this context, Escobar
etal, 2023 (7) mentioned that in the
overall HF population, mean age was 69.7 (19.0) years and 53.8% of patients
were men. Regarding comorbidities, 59.1% of patients had hypertension, 27.6%
type 2 diabetes, 33.1% coronary artery disease, 28.2% atrial fibrillation and
26.7% chronic kidney disease.
In relation to the medical health history of the studied patients ,the
current study mentions that (70% and 72.0%,61% and 14%) of the studied patients
had NYHA functional class III
respectively .and CCS angina grade III ,
3-vessels disease and left main
stem disease .this result is matched with Chandra etal,2018 (8) who
mentioned that most of the patients had
dilated cardiomyopathy (61 [73.5%] with an EF<0.5), CCS functional class
II-III, and sinus rhythm .Also, the studied patients were receiving Beta-blockers
and statins by (64% and 39%)
respectively. This result is mismatched with who Escobar etal, 2023 (7), mentioned that 1% of the studied patients were
taking beta-blockers, 56.3% renin-angiotensin system inhibitors, 11.8%
mineralocorticoid receptor antagonists and 8.9% SGLT2 inhibitors.
Concerning the Changes in the findings of trans-thoracic
echocardiography pre & postoperatively and at the end of follow-up period
in survivors. The current study shows that the studied patients had
preoperative left ventricular end-diastolic diameter (LVEDD), left ventricular
end-systolic diameter (LVESD) and left ventricular ejection fraction (LVEF) of
5.12 ± 0.45 cm of 4.25 ± 0.21 cm and 40.32 ± 1.36 respectively while the same
parameters were
4.97 ± 0.37,3.96 ± 0.21 and 56.21 ± 3.21 postoperatively. In this context, Stankowski et.al, 2024 (9) stated that at discharge, the mean
postoperative transvalvular pressure gradient was
15.1±8.4 mmHg and was comparable between both groups. Paravalvular
leak (PVL) occurred in 44 (38.6%) patients, however, nearly 90% of them
presented mild PVL, and we did not observe any severe PVL after VIV-TAVI. Both
LVEF and tricuspid annular plane systolic excursion did not significantly
change after VIV-TAVI, and there were no differences between groups before and
after PSM.
Also, the studied patients had left ventricular end-diastolic diameter
(LVEDD), left ventricular end-systolic diameter (LVESD) and left ventricular
ejection fraction (LVEF) of 4.95 ±
0.42,3.46 ± 0.31 and 59.7 ± 4.25respectively in the follow up period. This
result is in line with Stankowski etal, 2024 (9), who mentioned that in the follow-up period, 71(62.3%) patients
survived, 59 (70.2%) of them in the non-mild MR group, and 12 (40.0%) in the
moderate MR group. The overall survival probabilities at one, three, and five
years were 93.7%, 71.0%, and 53.8%. In the unmatched cohort, survival
probabilities at one, three, and five years were 96.3% vs. 86.3%, 74.6% vs.
60.9%, and 66.0% vs. 25.0 % in the none to mild MR group vs. moderate MR group,
respectively (log-rank P=0.003). In the matched cohort, survival probabilities
at one, three, and five years were 95.7% vs. 87.0%, 85.0% vs. 64.5%, and 85.0%
vs. 29.0% in the none to mild MR group vs. moderate MR group, respectively
(log-rank P=0.035)
Regarding SWAM, the apical contraction on TTE
was presented as hypokinesia, akinesia
and dyskinesia by (28.0%, 47.0% and 25.0%) respectively, while the same
parameters were 48 %, 5% and 0%) postoperatively while the apical contraction
on TTE was presented as hypokinesia, akinesia and dyskinesia by (43% ,4% and 0%) respectively in
the follow up period. In this context, Meo et al,2020 (10), stated that Abnormal
ventricular wall motion is a strong clinical predictor of sudden, arrhythmic,
cardiac death. Dispersion in repolarization is a prerequisite for the initiation
of re-entrant arrhythmia, The patient group with Wall motion abnormality was
included six patients with hypokinesia and six
patients with akinesia or dyskinesia in which
dispersion of ARIs between the nine segments was significantly increased in the
hypokinetic (84 ± 7.4 ms, p < 0.005)
and akinetic/dyskinetic
group (94 ± 3.5 ms, p < 0.0005)
compared with the normal group (49 ± 5.1 ms)
There was highly statistical significance
between the findings of trans-thoracic echocardiography pre & postoperatively
and at the end of follow-up period in which p<0.001. This result is
mismatched with Papestiev etal,2023 (11) who mentioned that Preoperative global
longitudinal strain was reduced (GLS < −17%) in 39% of the patients.
Parameters of systolic LV function were significantly reduced in this group of
patients compared to the patient group with GLS% ≥ −17%. In both
groups, 4 months after CABG there was a decline in LVEF but statistically
significant only in the group with GLS% ≥ −17% (p = 0.035).
In patients with reduced GLS, there was a statistically significant
postoperative improvement (p = 0.004). In patients with preoperative
normal GLS, there was not a significant change in any strain parameters after
CABG. There was an improvement in diastolic function parameters measured by
Tissue Doppler Imaging (TDI) in both groups.
In relation to Multivariable analysis of the
associated factors of in-hospital mortality after CABG in patients with low
LVEF (Cox Proportional Hazards Regression Analysis ,the current study shows
that Insertion of IABP is highly significant associated factor with in hospital
mortility p<0.001 ) this result is mis matched with Talukder etal,2022 (12) who illustrated that
Preoperative factors that were identified as statistically significant
predictors of 10-year mortality in the multivariable analysis (all P ≤ 0.01)
were: left ventricular ejection fraction, atrial fibrillation, age, diabetes,
prior cerebrovascular event (stroke or transient ischemic attack), serum
creatinine and smoking status. The following variables were significantly
associated in univariable models but did not retain
significance in the multivariable model for mortality: non-Caucasian ethnicity,
hypertension, peripheral vascular disease, chronic obstructive pulmonary disease,
and prior myocardial infarction. Also, he mentioned that independent predictors
of 10-year mortality in the ART were identified including: heart function,
renal function, cerebrovascular disease, age, atrial fibrillation, smoking status,
and diabetes. Understanding which preoperative variables influence long-term
outcome after coronary artery bypass grafting may help to target treatments to
those at higher risk to reduce mortality. About Multivariable analysis of the associated
factors of functional non-recovery after CABG in patients with low LVEF (Binary
Logistic Regression Analysis) the current study mentions that Peak WMSI on DSE
>1.5, Improvement of
LVEF on DSE <10%
and Incomplete revascularization were at odd ratio and 95% IC of (4.72, 9.45 and 29.89)
respectively. The improvement of LVEF on DSE <10% and incomplete
revascularization were significant associated factors of functional
non-recovery. In this context, Rijnhart-de Jong etal,2020 (13), showed that (21.9%) did not display an improvement in the SF-36 physical domain
score 1 year after cardiac surgery. In a multivariate analysis independent
risk factors for non-recovery in the SF-36 physical domain were baseline SF36
physical domain score (OR 0.954[0.942–0.965], P < 0.001),
diabetes (OR 0.437 [0.265–0.720], P 0.001), female sex (OR 0.492 [0.307–0.789],
P 0.003), post-operative infection (OR 0.240 [0.109–0.525], P < 0.001)
and PCI within 1 year (OR 0.113 [0.036–0.349], P < 0.001)
For isolated CABG, 23.2% of patients did not display an improvement in the
physical domain score and risk factors appeared to be identical.
In relation to preoperative extent of coronary
artery disease, the current study shows that coronary revascularization was
complete in 74.0% and incomplete in 26.0%. Coming off bypass required inotropes
in 49.0% and IABP in 10.0%. in this context, Leviner (14) mentioned that Complete revascularization was
more often achieved with CABG than with PCI and is associated with a 30%
reduction in long-term mortality, a 22% reduction in MI, and a 26% reduction in
repeat coronary revascularization procedures. The lower mortality associated
with CR was seen in both PCI- and CABG-treated patients and was independent of
the study design and definition of CR. This is arguably the most
statistically powerful and rigorous assessment in the peer-reviewed literature
of the impact of CR and IR among both PCI a CABG patients with multivessel CAD. In relation to the Postoperative
complications, the current study showed that low cardiac output arrhythmia
reopening for bleeding (Sternal wound infection, pulmonary complications (and
renal complications were presented in (57.0%,15.0%,5.0%,3.0%,7.0% and 2.0%) of
the studied patients respectively. The mean duration of mechanical ventilation
and hospital stay was 25.32 ± 11.01
hours and 10.36 ± 2.36 days respectively. In this context,
Montrief (15), stated that post-CABG surgery complications
can affect many different systems other than the cardiovascular system, as
patients are at risk for common post-surgical complications, including
respiratory failure, stroke, urinary tract infections, renal failure,
coagulopathy, limb ischemia, wound dehiscence, pleural effusion, and
hematologic abnormalities.
This result is in line with Montrief (15), who mentioned that the incidence of 30-day
(in-hospital) mortality was 9.0%. CABG surgery is often considered a high-risk
procedure, associated with a 30-day morbidity and
mortality rate up to 14.0% and 2.0%, respectively there has been a widespread
institution of early extubation and fast track
protocols, which has resulted in earlier hospital discharge, with an average
post-op length of stay of 5.4 days.
Conclusion
In conclusion, our
study suggests that coronary artery bypass grafting (CABG) can lead to
significant improvements in cardiac function and quality of life in patients
with low ejection fraction. The study found an improvement in the patient's
symptoms and functional limitations. Additionally, there was an overall
improvement in cardiac function. However, the study also identified certain associated
factors of postoperative outcomes, including age > 60 years, peak WMSI on
DSE >1.5, improvement of LVEF on DSE <10%, insertion of IABP, and
incomplete revascularization, which were associated with an increased risk of
in-hospital mortality and functional non-recovery.
References
1. Liga R, Colli
A, Taggart DP, Boden WE, De Caterina
R. Myocardial revascularization in patients with ischemic cardiomyopathy: for
whom and how. Journal of the American Heart Association. 2023 Mar 21;12(6):e026943.
2. Babes EE, Tit DM, Bungau AF, Bustea C, Rus M, Bungau SG, Babes VV. Myocardial Viability Testing in the
Management of Ischemic Heart Failure. Life. 2022 Nov 1;12(11):1760.
3. Heusch G. Myocardial
stunning and hibernation revisited. Nature Reviews Cardiology. 2021 Jul;18(7):522-36.
4. Palmerini, T., Serruys,
P., Kappetein, A.P., Genereux,
P., Della Riva, D., Reggiani, L.B., Christiansen,
E.H., Holm, N.R., Thuesen, L., Makikallio,
T. and Morice, M.C., 2017. Clinical outcomes with
percutaneous coronary revascularization vs coronary
artery bypass grafting surgery in patients with unprotected left main coronary
artery disease: a meta-analysis of 6 randomized trials and 4,686 patients. American
heart journal, 190, pp.54-63.
5. Gu D, Qu
J, Zhang H, Zheng Z. Revascularization for coronary
artery disease: principle and challenges. Coronary Artery Disease: Therapeutics
and Drug Discovery. 2020:75-100.
6. Mourad, Faisal A; Sayed,
Gamal S; El-Gawad, Mostafa A-AA; Abdelkareem, Mostafa EK; Jawad, Mohammed NA.
Role of dobutamine-stress echocardiography in
prediction of clinical and functional improvement after coronary artery bypass
grafting in patients with low ejection fraction. The Egyptian Journal of
Surgery 41(1):p 335-339, January-March 2022. | DOI:
10.4103/ejs.ejs_360_21
7.
Escobar C, Palacios B, Gonzalez V,
Gutiérrez M, Duong M, Chen H, Justo N, Cid-Ruzafa J,
Hernández I, Hunt PR, Delgado JF. Evolution of economic burden of heart failure
by ejection fraction in newly diagnosed patients in Spain. BMC Health Services
Research. 2023 Dec 1;23(1):1340.
8.
Chandra A, Lewis EF, Claggett
BL, Desai AS, Packer M, Zile MR, Swedberg
K, Rouleau JL, Shi VC, Lefkowitz
MP, Katova T. Effects of sacubitril/valsartan
on physical and social activity limitations in patients with heart failure: a
secondary analysis of the PARADIGM-HF trial. JAMA cardiology. 2018 Jun 1;3(6):498-505.
9.
Stankowski T, Aboul-Hassan SS, Salem M, Rochor
K, Schenk S, Erkenov T, Zinab
FS, Muehle A, Herwig V, Harnath A, Sá MP. Prognostic
Impact of Residual Moderate Mitral Regurgitation Following Valve-in-Valve Transcatheter Aortic Valve Implantation. Brazilian Journal
of Cardiovascular Surgery. 2023 Oct 30;39: e20230012.
10.
Meo M, Bonizzi P, Bear LR, Cluitmans M, Abell E, Haïssaguerre M, Bernus O, Dubois R. Body surface mapping of ventricular
repolarization heterogeneity: an ex-vivo multiparameter
study. Frontiers in physiology. 2020 Aug 13; 11:933.
11.
Papestiev V, Jovev S, Risteski P, Popov AF, Sokarovski M, Andova V, Georgievska-Ismail L. Myocardial Function after Coronary
Artery Bypass Grafting in Patients with Preoperative Preserved Left Ventricular
Ejection Fraction—The Role of the Left Ventricular Longitudinal Strain. Medicina. 2023 May 12;59(5):932.
12.
Talukder S, Dimagli A, Benedetto U, Gray A,
Gerry S, Lees B, Krzych Ł, Gaudino
M, Taggart DP, Flather M, ART Investigators.
Prognostic factors of 10-year mortality after coronary artery bypass graft surgery:
a secondary analysis of the arterial revascularization trial. European Journal
of Cardio-Thoracic Surgery. 2022 Jun 1;61(6):1414-20.
13.
Rijnhart-de Jong H, Haenen J, Bol Raap
G, Jekel L, Vossenberg T, Bondarenko O, Boerma C.
Determinants of non-recovery in physical health-related quality of life one
year after cardiac surgery: a prospective single Centre observational study.
Journal of cardiothoracic surgery. 2020 Dec; 15:1-9.
14.
Leviner DB, Torregrossa G, Puskas
JD.
Incomplete revascularization: what the surgeon needs to know. Annals of
cardiothoracic surgery. 2018 Jul;7(4):463.
15.
Montrief T, Koyfman A, Long B. Coronary artery bypass graft
surgery complications: A review for emergency clinicians. The American journal
of emergency medicine. 2018 Dec 1;36(12):2289-97.
*
Author can be contacted at: Department
of Cardiovascular & Thoracic Surgery, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.Received: 10-February
2024; Sent for Review on: 15-February 2024; Draft sent to Author for
corrections: 28-February 2024; Accepted on:
16 -March 2024
Online Available from 26-March 2024
DOI: 10.13140/RG.2.2.17336.76805
IJLS-9180/© 2024 CRDEEP Journals.
All Rights Reserved.